Paper Details

  1. Home
  2. Paper Details

[Controlled randomized trials of pharmaceutic aids for smoking cessation. Results and perspectives].

Author: BerlinI, PuechA J, SaidS

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Nicotine patches and nasal spray have been studied for smoking cessation. Quit rates at 3 months using nicotine patches range from 14% to 39%, and one year quit rates range from 9% to 26%. While nasal spray has similar results, it is less well tolerated. These treatments are not entirely effective, and research on long-term outcomes (beyond 1 year) is lacking. Focusing on the psychological factors of smokers (depression, anxiety) and developing targeted treatments may be more promising.
Paper Details　
Original Abstract of the Article :
In several cases tobacco smoking fulfills criteria for drug dependence. Withdrawal symptoms after smoking cessation are considered the main cause of relapses. We reviewed results of controlled clinical drug trials (testing nicotine patch, nicotine nasal spray, clonidine, buspirone and doxepin) in sm...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/7878597

データ提供：米国国立医学図書館（NLM）

Exploring the Effectiveness of Pharmaceutic Aids in Smoking Cessation

The path to quitting smoking is a challenging one, akin to navigating a treacherous desert. This study delves into the effectiveness of various pharmaceutical aids, such as nicotine patches, nasal sprays, and medications like clonidine, buspirone, and doxepin, in helping individuals overcome nicotine dependence. The study reviewed controlled clinical trials and found that while these aids can help, the success rates vary. The effectiveness of these aids in achieving long-term cessation (over a year) is still under investigation, highlighting the need for continued research.

Nicotine Replacement Therapy: A Promising Step Toward a Smoke-Free Life

The study found that nicotine patches and nasal sprays offer varying levels of success in helping people quit smoking. However, the long-term effectiveness of these methods requires further research. The study emphasizes the need for a personalized approach, taking into account factors like the smoker's individual psychopathology, such as depression or anxiety, to develop more effective interventions. The effectiveness of nicotine replacement therapy, while promising, is not a magic bullet. It's important to acknowledge the individual's unique circumstances and provide support beyond medication.

Navigating the Challenges of Nicotine Dependence

The journey to quit smoking is often marked by withdrawal symptoms and a persistent craving for nicotine. This study underscores the importance of addressing the individual's specific needs and providing comprehensive support, including psychological interventions, to increase the likelihood of successful cessation. While pharmaceutical aids can play a role, it's crucial to remember that quitting smoking is a multifaceted process that requires personalized strategies and ongoing support.

Dr. Camel's Conclusion

This study provides valuable insights into the effectiveness of various pharmaceutic aids in helping people quit smoking. However, it also highlights the need for further research to develop more effective and sustainable solutions. It is crucial to remember that quitting smoking is a personal journey, and the path to success may involve a combination of strategies tailored to the individual's unique needs.

Date :
  1. Date Completed 1995-04-06
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

7878597

DOI: Digital Object Identifier

7878597

SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.